TLR4 and TLR9 polymorphisms are not associated with either rheumatoid arthritis or systemic lupus erythematosus in Mexican patients
Toll-like receptor (TLR)-mediated signaling pathways induce a proinflammatory microenvironment to eradicate pathogens. However, in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), TLRs can promote chronic inflammation. It has been shown that some TLR4 and TLR9 single nucleotide poly...
Saved in:
Published in: | Molecular biology reports Vol. 48; no. 4; pp. 3561 - 3565 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Dordrecht
Springer Netherlands
01-04-2021
Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Toll-like receptor (TLR)-mediated signaling pathways induce a proinflammatory microenvironment to eradicate pathogens. However, in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), TLRs can promote chronic inflammation. It has been shown that some
TLR4
and
TLR9
single nucleotide polymorphisms (SNPs) are risk factors for RA and SLE, but these findings have not been replicated in all populations; thus, results are inconclusive. We evaluated the
TLR4
Asp299Gly, Thr399Ile, − 1892G/A SNPs, and the
TLR9
Pro545Pro SNP to assess potential associations with RA and SLE in Mexican patients. This study included 474 patients with RA, 283 patients with SLE, and 424 healthy controls. We used a 5′ nuclease allelic discrimination assay to genotype individuals for the four
TLR4
and
TLR9
polymorphisms. We found that the genotype or allelic frequencies of the
TLR4
Asp299Gly, Thr399Ile, − 1892G/A, and
TLR9
Pro545Pro polymorphisms were similar between patients and controls. We found no association under different genetic models. A haplotype analysis of
TLR4
showed no association with either RA or SLE. We found no significant differences in the allelic or genotypic frequencies of
TLR4
Asp299Gly, Thr399IIe, − 1892G/A, or
TLR9
Pro545Pro between patients and controls. These findings suggested that these variants are not risk factors for RA or SLE in Mexican patients. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0301-4851 1573-4978 |
DOI: | 10.1007/s11033-021-06371-4 |